Home Compare SAN.PA vs TRI
Stock Comparison · Comparison

Sanofi vs Thomson Reuters: Which Stock Looks Stronger in 2026?

Thomson Reuters holds the cleaner structural position, with profitability as the main driver and stability adding further support. Sanofi still leads on growth and stability, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The comparison is mainly decided in profitability, with the rest of the profile carrying less weight. The overall score gap is 12 points in favour of Thomson Reuters Corporation.

Trajectory Similarity
0.59
Moderately similar
Peer-set rank: #10
within Sanofi's functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

The pair shares a valid long-term profile match, but the trajectories are not especially close.

The strongest overlap appears in revenue stability and margin consistency.

Similarity drivers
revenue stabilitymargin consistency
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
SAN.PA
Sanofi
46
Peer-Score
Signal qualityHigh
vs
TRI
Thomson Reuters Corporation
58
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: SAN.PA vs TRI Profitability 16 69 Stability 67 41 Valuation 59 72 Growth 51 40 SAN.PA TRI
Gap Ranking
#1 Profitability +53
#2 Stability +26
#3 Valuation +13
#4 Growth +11
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for SAN.PA and TRI Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer SAN.PATRI Relative valuation Structural strength

Thomson Reuters Corporation and Sanofi look relatively close on structure, but the price setup still leans toward Thomson Reuters Corporation.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
Thomson Reuters Corporation ranks near the top of the group on profitability; Sanofi sits in the weaker half.
Stability
On stability, the same pattern holds: both are strong, but Sanofi still leads clearly.
Profitability — Dominant Gap
SAN.PA
16
TRI
69
Gap+53in favour of TRI

The profitability lead is mainly driven by a 12.3-point operating margin advantage.

What keeps the gap from being one-sided

A meaningful counterforce remains in stability, which keeps the comparison from looking completely one-sided.

What this means for the comparison

The profitability edge is decisive, even though current pricing and stability still lean somewhat toward Sanofi.

Explore full peer positioning in AssetNext

Break down the SAN.PA vs TRI comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how SAN.PA and TRI each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.